OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID 19: a clue from innate immunity
Domenico Birra, Maurizio Benucci, Luigi Landolfi, et al.
Immunologic Research (2020) Vol. 68, Iss. 3, pp. 161-168
Open Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells
Xin Yin, Laura Riva, Yuan Pu, et al.
Cell Reports (2021) Vol. 34, Iss. 2, pp. 108628-108628
Open Access | Times Cited: 347

Role of Toll‐like receptors in the pathogenesis of COVID‐19
Shaghayegh Khanmohammadi, Nima Rezaei
Journal of Medical Virology (2021) Vol. 93, Iss. 5, pp. 2735-2739
Open Access | Times Cited: 313

The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies
Lea Skak Filtenborg Frederiksen, Yibang Zhang, Camilla Foged, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 275

The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients
Apurva Hariharan, Abdul Rahman Hakeem, Subathra Radhakrishnan, et al.
Inflammopharmacology (2020) Vol. 29, Iss. 1, pp. 91-100
Open Access | Times Cited: 266

Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19
Jesús F. Bermejo-Martín, Milagros González‐Rivera, Raquel Almansa, et al.
Critical Care (2020) Vol. 24, Iss. 1
Open Access | Times Cited: 242

Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
Laura Kate Gadanec, Kristen Renee McSweeney, Tawar Qaradakhi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 992-992
Open Access | Times Cited: 133

COVID-19 and the clinical course of rheumatic manifestations
Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan
Clinical Rheumatology (2021) Vol. 40, Iss. 7, pp. 2611-2619
Open Access | Times Cited: 116

Prospective Roles of Tumor Necrosis Factor-Alpha (TNF-α) in COVID-19: Prognosis, Therapeutic and Management
Zarina Mohd Zawawi, Jeevanathan Kalyanasundram, Rozainanee Mohd Zain, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6142-6142
Open Access | Times Cited: 41

Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis
Irene Pastis, Melody G. Santos, Akshita Paruchuri
Frontiers in Behavioral Neuroscience (2024) Vol. 17
Open Access | Times Cited: 18

Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel
Nufar Marcus, Shirly Frizinsky, David Hagin, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 95

Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody
Simon Gebremeskel, Julia Schanin, Krysta M. Coyle, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 95

Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19
Jayanta Talukdar, Bhaskar Bhadra, Tomal Dattaroy, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110886-110886
Open Access | Times Cited: 91

Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review
Baoming Liu, Harry R. Hill
Journal of Interferon & Cytokine Research (2020) Vol. 40, Iss. 12, pp. 549-554
Open Access | Times Cited: 87

Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics
Konstantin Chumakov, Michael S. Avidan, Christine Stabell Benn, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 21
Open Access | Times Cited: 86

Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective
Choongho Lee, Won Jun Choi
Archives of Pharmacal Research (2021) Vol. 44, Iss. 1, pp. 99-116
Open Access | Times Cited: 83

TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target
Gillina F. G. Bezemer, Johan Garssen
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 66

Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System
Jacob Roberts, Antonia L. Pritchard, Andrew T. Treweeke, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 7
Open Access | Times Cited: 60

Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Yujie Jiang, Tingmei Zhao, Xueyan Zhou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 42

Immune dysfunction following COVID-19, especially in severe patients
Cong-Ying Song, Jia Xu, Jianqin He, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 67

Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges
Laura Marinela Ailioaie, Gerhard Litscher
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4942-4942
Open Access | Times Cited: 47

COVID-19: captures iron and generates reactive oxygen species to damage the human immune system
Wenzhong Liu, Li hualan
Autoimmunity (2021) Vol. 54, Iss. 4, pp. 213-224
Open Access | Times Cited: 43

Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis
Rafaela Pires da Silva, João Ismael Budelon Gonçalves, Rafael Fernandes Zanin, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 43

The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease
Don A. Davies, Aida Adlimoghaddam, Benedict C. Albensi
Molecular Neurobiology (2021) Vol. 58, Iss. 8, pp. 4178-4187
Open Access | Times Cited: 41

Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19
Marine Peyneau, Vanessa Granger, Paul-Henri Wicky, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 35

Page 1 - Next Page

Scroll to top